Breast cancer: This Nvidia-powered AI tool predicts cancer recurrence risk before surgery — here's how it works
Livemint AI ·
Summary: The tool represents an additional approach to estimating breast cancer recurrence risk using MRI-derived information. It may help inform discussions about treatment.
Read the full story on Livemint AIExplore more: Today in AI · Research papers · AI tools · Learn AI
Related stories
- ET Government · 29 Oct 2026 · policyTamil Nadu extends free bus travel scheme to persons with disabilities and escorts
- Livemint · 29 Oct 2026AI investment boom in India: Which sectors beyond IT could benefit from data centres, power and electronics growth?
- Kashmir Convener · 29 Oct 2026 · policyApollo Knowledge City Positions Chittoor as Hub for Medical Education, Research: VC Prof Nagarkar
- MediaNama · 29 Oct 2026 · policyUPI MDR set to deliver Rs 700 crore windfall for Paytm
Paytm could earn up to Rs 700 crore annually from UPI MDR, with gains potentially reaching Rs 900 crore by FY28. The company is also targeting UPI market share growth, lending expansion and AI services. The post UPI MDR set to deliver Rs 700 crore windfall for Paytm appeared firs
- India Today · 29 Oct 2026Google shares crash 13% as AI spending spooks investors
- PIB (Govt of India) · 29 Oct 2026 · policyAIIA-iCAINE Marks Sixth Foundation Day with Launch of National Ayurveda AI Challenge in Collaboration with Techfest, IIT Bombay
Where is this story from?
This is a summary of a story first published by Livemint AI on 29 Oct 2026. Read the full article at the source link.
How does Deekoya AI choose news?
We track approved, reputable sources daily and link every item to its original publisher.